0001144204-17-021382.txt : 20170420 0001144204-17-021382.hdr.sgml : 20170420 20170420211635 ACCESSION NUMBER: 0001144204-17-021382 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170419 FILED AS OF DATE: 20170420 DATE AS OF CHANGE: 20170420 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLx Pharma Inc. CENTRAL INDEX KEY: 0001497504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271707962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 BUSINESS PHONE: (713) 842-1249 MAIL ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20140313 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC DATE OF NAME CHANGE: 20100726 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: JORDEN DAVID EMERSON CENTRAL INDEX KEY: 0001313516 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36351 FILM NUMBER: 17774029 MAIL ADDRESS: STREET 1: 2635 TECHNOLOGY FOREST BLVD. CITY: THE WOODLANDS STATE: TX ZIP: 77381 4 1 v464780_4.xml OWNERSHIP DOCUMENT X0306 4 2017-04-19 0 0001497504 PLx Pharma Inc. PLXP 0001313516 JORDEN DAVID EMERSON 8285 EL RIO STREET, SUITE 130 HOUSTON TX 77054 0 1 0 0 Acting Chief Financial Officer Common Stock 2017-04-19 4 A 0 119186 A 119186 D Options 12.44 2017-04-19 4 A 0 33753 0 A 2017-04-19 2025-07-22 Common Stock 33753 33753 D Received in exchange for 151,336 shares of common stock of PLx Opco Inc. (formerly PLx Pharma Inc.) in connection with the merger (the "Merger") of PLx Opco Inc. with a wholly owned subsidiary of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.). Received in connection with the Merger in exchange for an employee stock option to buy 42,857 shares of PLx Opco Inc. common stock for $9.80 per share. /s/ David E. Jorden 2017-04-20